Clinical Trial 49293

Miami, FL 33186


The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.

Qualified Participants Must:

• Adults aged 40 years and older, with COPD and with chronic bronchitis
• Current smokers or ex-smokers (history of 10 pack years or higher)
• Post-bronchodilator FEV1 less than 50% of the patient predicted normal value and FEV1/FVC ratio less than 0.7
• At least, one moderate or severe COPD exacerbation in the previous year
• CAT score greater than 10
• Subjects on regular maintenance triple therapy for at least 12 months

Qualified Participants May Receive:

May receive reimbursement for time and travel for study participation, if you qualify.

Available At:

Clinical Site Partners, LLC
12600 SW 120 Street
Suite 116 & 117
Miami, FL 33186
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.